Accessibility: Skip TopNav
Ph2 Data
1. In the REC-400 mg arm these consisted of dizziness, rash, anemia, nausea and peripheral edema. In the placebo arm these consisted of dizziness and erythema multiforme. Across both arms, TEAEs related to study drug were Grade 1 or 2.
Format
JPEG
Source
Recursion Pharmaceuticals, Inc.
Downloads
Original
Large
Medium
Small